Handelsbanken Fonder
LGND icon

Handelsbanken Fonder’s Ligand Pharmaceuticals LGND Stock Holding History

Handelsbanken Fonder’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.27M Buy
10,358
+1,900
+22% +$448K 0.01% 632
2026
Q1 		$1.69M Buy
8,458
+2,100
+33% +$415K 0.01% 806
2025
Q4 		$1.2M Hold
6,358
– – ﹤0.01% 956
2025
Q3 		$1.13M Hold
6,358
– – ﹤0.01% 961
2025
Q2 		$723K Sell
6,358
-300
-5% -$32.1K ﹤0.01% 1092
2025
Q1 		$700K Buy
6,658
+800
+14% +$90.5K ﹤0.01% 1097
2024
Q4 		$628K Buy
5,858
+500
+9% +$56.5K ﹤0.01% 1196
2024
Q3 		$536K Buy
5,358
+500
+10% +$50.3K ﹤0.01% 1211
2024
Q2 		$409K Buy
4,858
+1,200
+33% +$95.5K ﹤0.01% 1243
2024
Q1 		$267K Hold
3,658
– – ﹤0.01% 1426
2023
Q4 		$261K Hold
3,658
– – ﹤0.01% 1433
2023
Q3 		$219K Hold
3,658
– – ﹤0.01% 1437
2023
Q2 		$264K Buy
+3,658
New +$274K ﹤0.01% 1396
2022
Q3 		– Sell
-5,062
Closed -$282K – 1575
2022
Q2 		$282K Hold
5,062
– – ﹤0.01% 1360
2022
Q1 		$355K Hold
5,062
– – ﹤0.01% 1422
2021
Q4 		$488K Buy
5,062
+962
+23% +$88.9K ﹤0.01% 1366
2021
Q3 		$356K Hold
4,100
– – ﹤0.01% 1533
2021
Q2 		$336K Buy
4,100
+320
+8% +$26.6K ﹤0.01% 1594
2021
Q1 		$359K Sell
3,780
-2,404
-39% -$227K ﹤0.01% 1367
2020
Q4 		$384K Hold
6,184
– – ﹤0.01% 1294
2020
Q3 		$368K Hold
6,184
– – ﹤0.01% 1145
2020
Q2 		$432K Buy
+6,184
New +$392K ﹤0.01% 1029

Other funds holding LGND

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Handelsbanken Fonder's LGND Position: Q2 2026 in Review

Handelsbanken Fonder increased its Ligand Pharmaceuticals (LGND) stake by 22% in Q2 2026, buying an estimated $448K and bringing the position to 10,358 shares worth $3.27M. The position accounts for 0.01% of the portfolio, ranked #632.

Handelsbanken Fonder first reported a position in LGND in Q2 2020 and has held it in 22 quarters since. 171 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Handelsbanken Fonder held 10,358 shares of Ligand Pharmaceuticals worth $3.27M as of Q2 2026.
  • Handelsbanken Fonder bought 1,900 Ligand Pharmaceuticals shares in Q2 2026, an estimated $448K.
  • Ligand Pharmaceuticals made up 0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #632 holding.
  • Handelsbanken Fonder first reported a position in Ligand Pharmaceuticals in Q2 2020 and has held it in 22 quarters since.
  • 171 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.